Delivery of Acetogenin-enriched Annona Muricata Linn Leaf Extract by Folic Acid-conjugated and Triphenylphosphonium-conjugated Poly(glycerol Adipate) Nanoparticles to Enhance Toxicity Against Ovarian Cancer Cells
Overview
Authors
Affiliations
The study demonstrated the fabrication of new poly(glycerol adipate) (PGA) nanoparticles decorated with folic acid (FOL-PGA) and triphenylphosphonium (TPP-PGA) and the potential on the delivery of acetogenin-enriched Annona muricata Linn leaf extract to ovarian cancer cells. FOL-PGA and TPP-PGA were successfully synthesized and used to fabricate FOL-decorated nanoparticles (FOL-NPs) and FOL-/TPP- decorated nanoparticles (FOL/TPP-NPs) by blending two polymers at a mass ratio of 1:1. All nanoparticles had small size of around 100 nm, narrow size distribution and high negative surface charge about -30 mV. The stable FOL/TPP-NPs showed highest drug loading of 14.9 ± 1.9% at 1:5 ratio of extract to polymer and reached to 35.8 ± 2.1% at higher ratio. Both nanoparticles released the extract in a biphasic sustained release manner over 5 days. The toxicity of the extract to SKOV3 cells was potentiated by FOL-NPs and FOL/TPP-NPs by 2.0 - 2.6 fold through induction of cell apoptosis. FOL/TPP-NPs showed lower IC and higher cellular uptake as compared to FOL-NPs. FOL-NPs exhibited folate receptor-mediated endocytosis. FOL/TPP-NPs provided more advantages than FOL-NPs in terms of stability in physiological fluid, uptake efficiency and targeting ability to mitochondria and showed a promising potential PGA platform for targeted delivery of herbal cytotoxic extracts.
Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects.
Cheng Z, Huang H, Yin M, Liu H Exp Hematol Oncol. 2025; 14(1):11.
PMID: 39891180 PMC: 11786384. DOI: 10.1186/s40164-025-00602-1.
Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges.
Andreani T, Cheng R, Elbadri K, Ferro C, Menezes T, Dos Santos M Drug Deliv Transl Res. 2024; 14(10):2845-2916.
PMID: 39003425 PMC: 11385056. DOI: 10.1007/s13346-024-01649-z.
Suksiriworapong J, Achayawat C, Juangrattanakamjorn P, Taresco V, Cuzzucoli Crucitti V, Sakchaisri K Pharmaceutics. 2023; 15(8).
PMID: 37631315 PMC: 10459774. DOI: 10.3390/pharmaceutics15082100.
CD44-Targeted Lipid Polymer Hybrid Nanoparticles Enhance Anti-Breast Cancer Effect of Extracts.
Suksiriworapong J, Pongprasert N, Bunsupa S, Taresco V, Cuzzucoli Crucitti V, Janurai T Pharmaceutics. 2023; 15(6).
PMID: 37376218 PMC: 10302493. DOI: 10.3390/pharmaceutics15061771.
Rostami N, Gomari M, Abdouss M, Moeinzadeh A, Choupani E, Davarnejad R ACS Appl Bio Mater. 2023; 6(5):1806-1815.
PMID: 37093754 PMC: 10629236. DOI: 10.1021/acsabm.3c00041.